Therapeutics

Current Therapeutics
12. References
1. Ziment I. Acetylcysteine: a drug with an interesting past and a
fascinating future. Respiration 1986; 50 Suppl. 1: 26-30
2. Richardson PS. The physical and chemical properties of airway mucus
and their relation to airway function. Eur J Respir Dis 1980; 61 Suppl. 111:
13-15
3. Van As A. Pulmonary airway defence mechanisms: an appreciation of
integrated mucociliary activity. Eur J Respir Dis 1980; 61 Suppl. 111: 21-4
4. Puchelle E, Polu JM, Zahm JM, et al. Role of the rheological properties of
bronchial secretions in the mucociliary transport at the bronchial surface.
Eur J Respir Dis 1980; 61 Suppl. 111: 29-34
5. Houtmeyers E, Gosselink R, Bayanm-Ramirez G, et al. Effects of drugs
on mucous clearance. Eur Respir J 1999; 14: 452-67
6. Barton AD, Lurenço RV. Bronchial secretions and mucociliary clearance:
biochemical characteristics. Arch Intern Med 1973; 131: 140-4
7. Tomasi A. New acquisitions and therapeutic role of N-acetylcysteine in
airways diseases caused by cigarette smoke and pollution. Eur Rev Med
Pharmacol Sci 2004; 8 (3 Suppl. 1): 4-28
8. Mossberg B, Camner P. Mucociliary transport and cough as clearance
mechanisms in obstructive lung disease. Eur J Respir Dis 1980; 61 Suppl.
111: 18-20
9. Streightoff F, Redman CE., Delong DC. In vivo antiviral chemotherapy.
II. Anti-influenza action of compounds affecting mucous secretions.
Antimicrob Ag Chemother 1966; 6: 503-8
10. Cordier JF. Oxidant-antioxidant balance. Bull Eur Physiopathol Respir
1987; 23: 273-4
11. Schraufstatter IU, Hyslop PA, Jackson J, et al. Oxidant and protease
injury of the lung. Bull Eur Physiopathol Respir 1987; 23: 297-302
12. Rahman I, MacNee W. Oxidative stress and adaptive response of
glutathione in bronchial epithelial cells. Clin Exp Allergy 2002; 32 (4):
486-8
13. Housset B. Biochemical aspects of free radicals metabolism. Bull Eur
Physiopathol Respir 1987; 23: 287-90
14. Dekhuijzen PNR. Antioxidant properties of N-acetylcysteine: their
relevance in relation to chronic obstructive pulmonary disease. Eur
Respir J 2004; 23: 629-36
15. Holt PG. Immune and inflammatory function in cigarette smokers.
Thorax 1987; 42 (4): 241-9
16. Cotgreave IA, Moldéus P. Lung protection by thiol-containing
antioxidants. Bull Eur Physiopathol Respir 1987; 23: 275-7
17. Greenwell LL, Moreno T, Richards RJ. Pulmonary antioxidants exert
differential protective effects against urban and industrial particulate
matter. J Biosci 2003; 28 (1): 101-7
18. Ungheri D, Pisani C, Sanson G, et al. Protective effect of N-acetylcysteine
in a model of influenza infection in mice. Int J Immunopathol Pharmacol
2000; 13 (3): 123-8
19. Ghezzi P, Ungheri D. Synergistic combination of N-acetylcysteine and
ribavirin to protect from lethal influenza viral infection in a mouse
model. Int J Immunopathol Pharmacol 2004; 17 (1): 99-102
20. Knobil K, Choi AM, Weigand GW, et al. Role of oxidants in influenza
virus-induced gene expression. Am J Physiol 1998; 274 (1 Pt 1): L134-42
21. Stagnaro R, Pierri I, Piovano P, et al. Thiol containing antioxidant drugs
and the human immune system. Bull Eur Physiopathol Respir 1987; 23:
303-7
22. Arranz L, Rodríguez A, Fernández C, et al. Un tratamiento de 2 meses
con N-acetilcisteína mejora la función leucocitaria en mujeres mayores de
50 años [abstract]. Rev Esp Geriatr Gerontol 2005; 40 (Suppl. 1): 21
23. Arranz L, Rodríguez A, Fernández C, et al. Efecto de un tratamiento de 2
mesesconN-acetilcisteínasobrelafuncióndeneutrófilos en mujeres mayores
de 50 años [abstract]. Rev Esp Geriatr Gerontol 2005; 40 (Suppl. 1): 116
24. Ventresca GP, Cicchetti V, Ferrari V. Acetylcysteine. In: Braga PC, Allegra L,
editors. Drugs in Bronchial Mucology. New York: Raven Press, 1989: 77-102
25. Fluimucil: summary of product characteristics. 2002
26. Borgström L, Kågedal B. Dose dependent pharmacokinetics of N-
acetylcysteine after oral dosing to man. Biopharm Drug Dispos 1990; 11
(2): 131-6
27. De Caro L, Ghizzi A, Costa R, et al. Pharmacokinetics and bioavailability
of oral acetylcysteine in healthy volunteers. Arzneimittelforschung 1989;
39 (3): 382-6
28. Tegner H, Torelmalm NG. Interaction between N-acetylcysteine and
cigarette smoke extract. Eur J Respir Dis 1985; 66 Suppl. 139: 130-1
29. Rogers DF, Godfrey RW, Majumdar S, et al. Oral N-acetylcysteine speeds
reversal of cigarette smoke-induced mucous cell hyperplasia in the rat.
Exp Lung Res 1988; 14 (1): 19-35
30. Rogers DF, Turner NC, Marriott C, et al. Oral N-acetylcysteine or S-
carboxymethylcysteine inhibit cigarette smoke-induced hypersecretion of
mucus in rat larynx and trachea in situ. Eur Respir J 1989; 2 (10): 955-60
31. Lightowler JE, Lightowler NM. Comparative mucolytic studies on
dithiothreitol, N-acetylcysteine and L-cysteine on human respiratory
mucus in vitro and their effects on the rate of flow of mucus in the
exposed trachea of the rat on topical application. Arch Int Pharmacodyn
Ther 1971; 189 (1): 53-8
32. Reggiani A, Galzigna L, Gaffuri E. Azione "in vitro" della N-acetil-Lcisteina
e della chemotripsina sulla viscosità della secrezione bronchiale.
Minerva Med 1964; 55: 2235-7
33. Sheffner AL. The reduction in vitro in viscosity of mucoprotein solutions
by a new mucolytic agent, N-acetyl-L-cysteine. Ann N Y Acad Sci 1963;
106: 298-310
34. Sheffner AL, Medler EM, Jacobs LW, et al. The in vitro reduction in
viscosity of human tracheobronchial secretions by acetylcysteine. Am
Rev Respir Dis 1964; 90: 721-9
35. Morandini GC, Perduca , Finiguerra M, et al. Recent advances of
knowledge on the mechanism of action of drugs modifying the bronchial
secretions. Int J Clin Pharm Res 1986; 6 (5): 415-23
36. Rochat T, Lacroix J-S, Jornot L. N-acetylcysteine inhibits Na + absorption
across human nasal epithelial cells. J Cell Physiol 2004; 201: 106-16
37. Iravani J, Melville GN, Horstmann G. N-Acetylcysteine and mucociliary
activity in mammalian airways. Arzneimittelforschung 1978; 28 (2): 250-4
38. Kogi K, Saito T, Kase Y et al. Pharmacological effects of N-acetyl-Lcysteine
on the respiratory tract. (1). Quantitative and qualitative changes
in respiratory tract fluid and sputum [In Japanese]. Nippon Yakurigaku
Zasshi 1981; 77 (6): 569-78
39. Hirsch SR, Kory RC. An evaluation of the effect of nebulized N-
acetylcysteine on sputum consistency. J Allergy 1967; 39 (5): 265-73
40. Olivieri D, Marsico SA, Del Donno M. Improvement of mucociliary
transport in smokers by mucolytics. Eur J Respir Dis 1985; 66 Suppl. 139:
142-5
26